Evidence map›Paper›PMID 37052678›Full record

SynthesisEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

Time to negative throat culture following initiation of antibiotics for pharyngeal group A

Emma McGuire, Ang Li, Simon M Collin, Valerie Decraene, Michael Cook, Simon Padfield, Shiranee Sriskandan, Chris Van Beneden, Theresa Lamagni, Colin S Brown

Erratum issuedOpen access · diamondAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Control of an outbreak of invasive Group AEpidemiology and infection · 2025
    Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Emma McGuireUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Ang LiUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Simon M CollinUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Valerie DecraeneUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Michael CookUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Simon PadfieldUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Shiranee SriskandanNIHR Health Protection Research Unit in Healthcare-associated Infection and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom.
Chris Van BenedenCDC Foundation, Atlanta, Georgia, United States.
Theresa LamagniUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Colin S BrownUnited Kingdom Health Security Agency (UKHSA), London, United Kingdom.
Hammersmith Hospital · GBCDC Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundPublic health guidance recommending isolation of individuals with group A streptococcal (GAS) infection or carriage for 12-24 h from antibiotic initiation to prevent onward transmission requires a strong evidence base.AimTo estimate the pooled proportion of individuals who remain GAS culture-positive at set intervals after initiation of antibiotics through a systematic literature review (PROSPERO CRD42021290364) and meta-analysis.MethodsWe searched Ovid MEDLINE (1946-), EMBASE (1974-) and Cochrane library. We included interventional or observational studies with ≥ 10 participants reporting rates of GAS throat culture positivity during antibiotic treatment for culture-confirmed GAS pharyngitis, scarlet fever and asymptomatic pharyngeal GAS carriage. We did not apply age, language or geographical restrictions.ResultsOf 5,058 unique records, 43 were included (37 randomised controlled studies, three non-randomised controlled trials and three before-and-after studies). The proportion of individuals remaining culture-positive on day 1, day 2 and days 3-9 were 6.9% (95% CI: 2.7-16.8%), 5.4% (95% CI: 2.1-13.3%) and 2.6% (95% CI: 1.6-4.2%). For penicillins and cephalosporins, day 1 positivity was 6.5% (95% CI: 2.5-16.1%) and 1.6% (95% CI: 0.04-42.9%), respectively. Overall, for 9.1% (95% CI: 7.3-11.3), throat swabs collected after completion of therapy were GAS culture-positive. Only six studies had low risk of bias.ConclusionsOur review provides evidence that antibiotics for pharyngeal GAS achieve a high rate of culture conversion within 24 h but highlights the need for further research given methodological limitations of published studies and imprecision of pooled estimates. Further evidence is needed for non-beta-lactam antibiotics and asymptomatic individuals.

Indexed as

PharyngitisStreptococcal InfectionsAnti-Bacterial AgentsHumansPharynxPublic HealthStreptococcus pyogenesAnti-Bacterial AgentsDisease TransmissionGroup A Strep InfectionInfectiousInfectious Disease OutbreaksStreptococcalStreptococcus pyogenes

Identifiers

PMID37052678
PMCPMC10103550
OpenAlexW4365442794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.